文献速递糖尿病

1型糖尿病患者中慢性肾脏病存在两种不同表型的证据

Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
PubMed 文献 · Diabetologia · 2017-03-29

结果显示,CKD分期≥3的个体中伴白蛋白尿表型占41.4%、不伴白蛋白尿表型占58.6%,两种表型关联因素不同,支持1型糖尿病进展至晚期肾病存在两条不同途径的假说。

要点

  • CKD分期≥3的个体中,不伴白蛋白尿表型占58.6%,伴白蛋白尿表型占41.4%。
  • eGFR 60-74 ml min-1 [1.73 m]-2者中,ACR<3.4 mg/mmol占88.7%,ACR<1.1 mg/mmol占70.4%。
  • 伴白蛋白尿CKD表型与糖尿病病程、HbA1c、HDL-胆固醇、纤维蛋白原和高血压相关。

核心结论

  • 不伴白蛋白尿的CKD表型在1型糖尿病患者中占相当比例,支持1型糖尿病进展至晚期肾病存在伴白蛋白尿和不伴白蛋白尿两条不同途径的假说。
  • 两种CKD表型关联的因素不同,提示可能为不同的进展途径。

研究设计与样本

  • 回顾性、观察性、横断面、单中心研究,2001至2009年连续纳入408名男性和369名女性白种1型糖尿病患者。
  • 纳入者年龄40.2±11.7岁,糖尿病病程19.4±12.2年,HbA1c 7.83±1.17%[62.0±12.9 mmol/mol]。
  • 所有个体均获取白蛋白与肌酐比值(ACR)和eGFR(肾脏病饮食改良公式)及CKD分期,CKD表型由盲法研究者判定。

主要发现

  • 正常白蛋白尿(ACR<3.4 mg/mmol)、微量白蛋白尿(ACR 3.4-34 mg/mmol)和大量白蛋白尿(ACR≥34 mg/mmol)分别占91.6%、6.4%和1.9%。
  • eGFR分类1(≥90 ml min-1 [1.73 m]-2)、2(60-89 ml min-1 [1.73 m]-2)和3(<60 ml min-1 [1.73 m]-2)分别占57.3%、39.0%和3.7%。
  • 多数参与者无CKD(89.4%),CKD 1-2期和≥3期分别占6.8%和3.7%;CKD≥3期的个体中伴白蛋白尿表型12例(41.4%)、不伴白蛋白尿表型17例(58.6%)。
  • ACR<3.4 mg/mmol者中正常白蛋白尿(<1.1 mg/mmol)占77.2%、轻度升高白蛋白尿(1.1-3.4 mg/mmol)占14.4%。
  • logistic回归分析中,CKD 1-2期和≥3期均与年龄、HbA1c、γ-谷氨酰转移酶、纤维蛋白原、高血压独立相关,与性别、BMI、吸烟、HDL-胆固醇或甘油三酯无关;纳入晚期视网膜病变后HbA1c从模型中移除。

关键数值与推荐

  • CKD伴白蛋白尿表型与糖尿病病程、HbA1c、HDL-胆固醇、纤维蛋白原和高血压相关。
  • CKD不伴白蛋白尿表型与年龄和高血压相关,与糖尿病病程、HbA1c和纤维蛋白原无关。
  • eGFR 60-74 ml min-1 [1.73 m]-2者中ACR<3.4 mg/mmol占88.7%、ACR<1.1 mg/mmol占70.4%;CKD≥3期者中ACR<1.1 mg/mmol占34.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: In a retrospective, observational, cross-sectional, single-centre study, we assessed the prevalence and correlates of different CKD phenotypes (with and without albuminuria) in a large cohort of patients of white ethnicity with type 1 diabetes. METHODS: From 2001 to 2009, 408 men and 369 women with type 1 diabetes (age 40.2 ± 11.7 years, diabetes duration 19.4 ± 12.2 years, HbA1c 7.83 ± 1.17% [62.0 ± 12.9 mmol/mol]) were recruited consecutively. Albumin-to-creatinine ratio (ACR) and eGFR (Modification of Diet in Renal Disease) were obtained for all individuals, together with CKD stage. Diabetic retinopathy and peripheral polyneuropathy were detected in 41.5% and 8.1%, respectively, and cardiovascular disease (CVD) occurred in 8.5%. Adjudications of CKD phenotype were made by blinded investigators. RESULTS: Normo- (ACR <3.4), micro- (ACR 3.4-34) or macroalbuminuria (ACR ≥34 mg/mmol) were present in 91.6%, 6.4% and 1.9% of individuals, respectively. eGFR categories 1 (≥90 ml min-1 [1.73 m]-2), 2 (60-89 ml min-1 [1.73 m]-2) and 3 (<60 ml min-1 [1.73 m]-2) were present in 57.3%, 39.0% and 3.7%, respectively. The majority of participants had no CKD (89.4%), while stages 1-2 and ≥3 CKD were detected in 6.8% and 3.7%, respectively. The albuminuric (Alb+) and non-albuminuric (Alb-) phenotypes were present in 12 (41.4%) and 17 (58.6%) individuals with stage ≥3 CKD, respectively. Individuals with an ACR <3.4 mg/mmol were subdivided into those with normal albuminuria (<1.1 mg/mmol; 77.2%) and mildly increased albuminuria (1.1-3.4 mg/mmol; 14.4%), and individuals with stage 2 CKD were subdivided into those with eGFR 75-89 ml min-1 [1.73 m]-2 and 60-74 ml min-1 [1.73 m]-2. ACR <3.4 mg/mmol (88.7%) and even <1.1 mg/mmol (70.4%) were common in individuals with eGFR 60-74 ml min-1 [1.73 m]-2. The prevalence of ACR <1.1 mg/mmol was lower but still significant (34.5%) in those with stage ≥3 CKD. In logistic regression analysis, stages 1-2 and ≥3 CKD were independently associated with age, HbA1c, γ-glutamyltransferase, fibrinogen, hypertension, but not with sex, BMI, smoking, HDL-cholesterol or triacylglycerol. Inclusion of advanced retinopathy removed HbA1c from the model. The CKD Alb+ phenotype correlated with diabetes duration, HbA1c, HDL-cholesterol, fibrinogen and hypertension, while the CKD Alb- phenotype was associated with age and hypertension, but not with diabetes duration, HbA1c and fibrinogen. CONCLUSIONS/INTERPRETATION: The Alb- CKD phenotype is present in a significant proportion of individuals with type 1 diabetes supporting the hypothesis of two distinct pathways (Alb+ and Alb-) of progression towards advanced kidney disease in type 1 diabetes. These are probably distinct pathways as suggested by different sets of covariates associated with the two CKD phenotypes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Penno G, Russo E, Garofolo M, et al. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus. Diabetologia. 2017. PMID: 28357502. doi:10.1007/s00125-017-4251-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。